Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer

SIMPLE SUMMARY: Diagnosing lung cancer requires invasive procedures with high risk of complications. Methylated tumor-specific DNA has been suggested as a biomarker for lung cancer. The present study aimed to develop and validate the biomarker methylated HOXA9 in fluid from the lung collected during...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Sara W. C., Andersen, Rikke F., Rasmussen, Kristian, Thomsen, Caroline Brenner, Hansen, Torben Frøstrup, Nederby, Line, Hager, Henrik, Jakobsen, Anders, Hilberg, Ole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393370/
https://www.ncbi.nlm.nih.gov/pubmed/34439376
http://dx.doi.org/10.3390/cancers13164223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393370/
https://www.ncbi.nlm.nih.gov/pubmed/34439376
http://dx.doi.org/10.3390/cancers13164223

Ejemplares similares